Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Egalet Corp (NASDAQ:EGLT)

1.12
Delayed Data
As of 12:36pm ET
 +0.01 / +0.90%
Today’s Change
1.01
Today|||52-Week Range
10.00
-85.36%
Year-to-Date
No recent news for Egalet Corp.

Today’s Trading

Previous close1.11
Today’s open1.11
Day’s range1.11 - 1.16
Volume144,923
Average volume (3 months)656,508
Market cap$47.8M
Dividend yield--
Data as of 12:36pm ET, 08/18/2017

Growth & Valuation

Earnings growth (last year)-25.85%
Earnings growth (this year)+21.08%
Earnings growth (next 5 years)--
Revenue growth (last year)-25.69%
P/E ratioNM
Price/Sales11.06
Price/Book5.25

Competitors

 Today’s
change
Today’s
% change
AGLEAeglea Bio Therapeut...0.000.00%
ATNMActinium Pharmaceuti...-0.01-1.67%
JNPJuniper Pharmaceutic...-0.05-1.11%
GNMXAevi Genomic Medicin...+0.01+0.75%
Data as of 12:50pm ET, 08/18/2017

Financials

Next reporting dateNovember 15, 2017
EPS forecast (this quarter)-$0.56
Annual revenue (last year)$17.0M
Annual profit (last year)-$90.6M
Net profit margin-534.26%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
President, Chief Executive Officer &
Director
Robert Samuel Radie
Chief Operating Officer &
Executive Vice President
Mark Strobeck
Corporate headquarters
Wayne, Pennsylvania

Forecasts